These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 16765562)
1. Detection of metastatic disease in patients with uveal melanoma using positron emission tomography. Francken AB; Fulham MJ; Millward MJ; Thompson JF Eur J Surg Oncol; 2006 Sep; 32(7):780-4. PubMed ID: 16765562 [TBL] [Abstract][Full Text] [Related]
2. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET). Servois V; Mariani P; Malhaire C; Petras S; Piperno-Neumann S; Plancher C; Levy-Gabriel C; Lumbroso-le Rouic L; Desjardins L; Salmon RJ Eur J Surg Oncol; 2010 Feb; 36(2):189-94. PubMed ID: 19775851 [TBL] [Abstract][Full Text] [Related]
3. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study. Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909 [TBL] [Abstract][Full Text] [Related]
4. Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma. Strobel K; Bode B; Dummer R; Veit-Haibach P; Fischer DR; Imhof L; Goldinger S; Steinert HC; von Schulthess GK Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1774-82. PubMed ID: 19495748 [TBL] [Abstract][Full Text] [Related]
5. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases. Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374 [TBL] [Abstract][Full Text] [Related]
6. Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT. Kato K; Kubota T; Ikeda M; Tadokoro M; Abe S; Nakano S; Nishino M; Kobayashi H; Ishigaki T J Nucl Med; 2006 Mar; 47(3):404-9. PubMed ID: 16513608 [TBL] [Abstract][Full Text] [Related]
8. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT. Akcali C; Zincirkeser S; Erbagcý Z; Akcali A; Halac M; Durak G; Sager S; Sahin E J Int Med Res; 2007; 35(4):547-53. PubMed ID: 17697533 [TBL] [Abstract][Full Text] [Related]
10. Whole body PET/CT for initial staging of choroidal melanoma. Finger PT; Kurli M; Reddy S; Tena LB; Pavlick AC Br J Ophthalmol; 2005 Oct; 89(10):1270-4. PubMed ID: 16170114 [TBL] [Abstract][Full Text] [Related]
11. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma. Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753 [TBL] [Abstract][Full Text] [Related]
12. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. Sahani DV; Kalva SP; Fischman AJ; Kadavigere R; Blake M; Hahn PF; Saini S AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET. Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889 [TBL] [Abstract][Full Text] [Related]
14. (123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial. Cachin F; Miot-Noirault E; Gillet B; Isnardi V; Labeille B; Payoux P; Meyer N; Cammilleri S; Gaudy C; Razzouk-Cadet M; Lacour JP; Granel-Brocard F; Tychyj C; Benbouzid F; Grange JD; Baulieu F; Kelly A; Merlin C; Mestas D; Gachon F; Chezal JM; Degoul F; D'Incan M J Nucl Med; 2014 Jan; 55(1):15-22. PubMed ID: 24263087 [TBL] [Abstract][Full Text] [Related]
15. FDG PET in early stage cutaneous malignant melanoma. McIvor J; Siew T; Campbell A; McCarthy M J Med Imaging Radiat Oncol; 2014 Apr; 58(2):149-54; quiz 266. PubMed ID: 24690243 [TBL] [Abstract][Full Text] [Related]
16. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging. Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma. Bastiaannet E; Uyl-de Groot CA; Brouwers AH; van der Jagt EJ; Hoekstra OS; Oyen W; Verzijlbergen F; van Ooijen B; Thompson JF; Hoekstra HJ Ann Surg; 2012 Apr; 255(4):771-6. PubMed ID: 22367443 [TBL] [Abstract][Full Text] [Related]
18. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma. Choudhary MM; Gupta A; Bena J; Emch T; Singh AD JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182 [TBL] [Abstract][Full Text] [Related]